233 related articles for article (PubMed ID: 27280849)
1. Oxidative Stress Mediates the Antiproliferative Effects of Nelfinavir in Breast Cancer Cells.
Soprano M; Sorriento D; Rusciano MR; Maione AS; Limite G; Forestieri P; D'Angelo D; D'Alessio M; Campiglia P; Formisano P; Iaccarino G; Bianco R; Illario M
PLoS One; 2016; 11(6):e0155970. PubMed ID: 27280849
[TBL] [Abstract][Full Text] [Related]
2. Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo.
Gills JJ; Lopiccolo J; Tsurutani J; Shoemaker RH; Best CJ; Abu-Asab MS; Borojerdi J; Warfel NA; Gardner ER; Danish M; Hollander MC; Kawabata S; Tsokos M; Figg WD; Steeg PS; Dennis PA
Clin Cancer Res; 2007 Sep; 13(17):5183-94. PubMed ID: 17785575
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells.
Brüning A; Friese K; Burges A; Mylonas I
Breast Cancer Res; 2010; 12(4):R45. PubMed ID: 20594311
[TBL] [Abstract][Full Text] [Related]
4. Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer.
Pathania D; Sechi M; Palomba M; Sanna V; Berrettini F; Sias A; Taheri L; Neamati N
Biochim Biophys Acta; 2014 Jan; 1840(1):332-43. PubMed ID: 23954204
[TBL] [Abstract][Full Text] [Related]
5. The HIV protease inhibitor nelfinavir down-regulates RET signaling and induces apoptosis in medullary thyroid cancer cells.
Kushchayeva Y; Jensen K; Recupero A; Costello J; Patel A; Klubo-Gwiezdzinska J; Boyle L; Burman K; Vasko V
J Clin Endocrinol Metab; 2014 May; 99(5):E734-45. PubMed ID: 24483157
[TBL] [Abstract][Full Text] [Related]
6. Juglanin induces apoptosis and autophagy in human breast cancer progression via ROS/JNK promotion.
Sun ZL; Dong JL; Wu J
Biomed Pharmacother; 2017 Jan; 85():303-312. PubMed ID: 27899257
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavir.
Shim JS; Rao R; Beebe K; Neckers L; Han I; Nahta R; Liu JO
J Natl Cancer Inst; 2012 Oct; 104(20):1576-90. PubMed ID: 23042933
[TBL] [Abstract][Full Text] [Related]
8. Nelfinavir, an HIV protease inhibitor, induces apoptosis and cell cycle arrest in human cervical cancer cells via the ROS-dependent mitochondrial pathway.
Xiang T; Du L; Pham P; Zhu B; Jiang S
Cancer Lett; 2015 Aug; 364(1):79-88. PubMed ID: 25937300
[TBL] [Abstract][Full Text] [Related]
9. Panobinostat and Nelfinavir Inhibit Renal Cancer Growth by Inducing Endoplasmic Reticulum Stress.
Okubo K; Isono M; Asano T; Sato A
Anticancer Res; 2018 Oct; 38(10):5615-5626. PubMed ID: 30275179
[TBL] [Abstract][Full Text] [Related]
10. Abrus agglutinin is a potent anti-proliferative and anti-angiogenic agent in human breast cancer.
Bhutia SK; Behera B; Nandini Das D; Mukhopadhyay S; Sinha N; Panda PK; Naik PP; Patra SK; Mandal M; Sarkar S; Menezes ME; Talukdar S; Maiti TK; Das SK; Sarkar D; Fisher PB
Int J Cancer; 2016 Jul; 139(2):457-66. PubMed ID: 26914517
[TBL] [Abstract][Full Text] [Related]
11. Nelfinavir induces liposarcoma apoptosis and cell cycle arrest by upregulating sterol regulatory element binding protein-1.
Chow WA; Guo S; Valdes-Albini F
Anticancer Drugs; 2006 Sep; 17(8):891-903. PubMed ID: 16940799
[TBL] [Abstract][Full Text] [Related]
12. Piper nigrum ethanolic extract rich in piperamides causes ROS overproduction, oxidative damage in DNA leading to cell cycle arrest and apoptosis in cancer cells.
de Souza Grinevicius VM; Kviecinski MR; Santos Mota NS; Ourique F; Porfirio Will Castro LS; Andreguetti RR; Gomes Correia JF; Filho DW; Pich CT; Pedrosa RC
J Ethnopharmacol; 2016 Aug; 189():139-47. PubMed ID: 27178634
[TBL] [Abstract][Full Text] [Related]
13. Nelfinavir induces TRAIL receptor upregulation in ovarian cancer cells.
Brüning A; Vogel M; Burger P; Rahmeh M; Gingelmaier A; Friese K; Lenhard M; Burges A
Biochem Biophys Res Commun; 2008 Dec; 377(4):1309-14. PubMed ID: 19000651
[TBL] [Abstract][Full Text] [Related]
14. Cadmium induces reactive oxygen species-dependent apoptosis in MCF-7 human breast cancer cell line.
Khojastehfar A; Aghaei M; Gharagozloo M; Panjehpour M
Toxicol Mech Methods; 2015 Jan; 25(1):48-55. PubMed ID: 25403798
[TBL] [Abstract][Full Text] [Related]
15. Re: selective inhibition of Her2-positive breast cancer cells by the HIV protease inhibitor nelfinavir.
Kapoor S
J Natl Cancer Inst; 2013 Oct; 105(19):1515. PubMed ID: 24052619
[No Abstract] [Full Text] [Related]
16. Selective targeting of breast cancer cells through ROS-mediated mechanisms potentiates the lethality of paclitaxel by a novel diterpene, gelomulide K.
Yang JC; Lu MC; Lee CL; Chen GY; Lin YY; Chang FR; Wu YC
Free Radic Biol Med; 2011 Aug; 51(3):641-57. PubMed ID: 21641992
[TBL] [Abstract][Full Text] [Related]
17. Nelfinavir, a new anti-cancer drug with pleiotropic effects and many paths to autophagy.
Gills JJ; Lopiccolo J; Dennis PA
Autophagy; 2008 Jan; 4(1):107-9. PubMed ID: 18000394
[TBL] [Abstract][Full Text] [Related]
18. LYG-202 exerts antitumor effect on PI3K/Akt signaling pathway in human breast cancer cells.
Zhao Y; Wang X; Sun Y; Zhou Y; Yin Y; Ding Y; Li Z; Guo Q; Lu N
Apoptosis; 2015 Sep; 20(9):1253-69. PubMed ID: 26153346
[TBL] [Abstract][Full Text] [Related]
19. Nelfinavir inhibits regulated intramembrane proteolysis of sterol regulatory element binding protein-1 and activating transcription factor 6 in castration-resistant prostate cancer.
Guan M; Fousek K; Chow WA
FEBS J; 2012 Jul; 279(13):2399-411. PubMed ID: 22540830
[TBL] [Abstract][Full Text] [Related]
20. Antitumour effects of a protease inhibitor, nelfinavir, in hepatocellular carcinoma cancer cells.
Sun L; Niu L; Zhu X; Hao J; Wang P; Wang H
J Chemother; 2012 Jun; 24(3):161-6. PubMed ID: 22759761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
